Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | |
| Operating Expenses | 550 | 0 | 14 |
| Operating Income | -550 | N/A | -14 |
| Pre-tax Income | -550 | 0 | -14 |
| Net Income Continuous | -550 | N/A | -14 |
| Net Income | $-550 | $N/A | $-14 |
| EPS Basic Total Ops | -1.40 | N/A | 0.00 |
| EPS Basic Continuous Ops | -1.38 | N/A | -0.04 |
| EPS Diluted Total Ops | -1.40 | N/A | 0.00 |
| EPS Diluted Continuous Ops | -1.38 | N/A | -0.04 |
| EBITDA(a) | $-550 | $N/A | $-14 |